This feedback regulation of FGF 19 in human hepatic bile acid synthesis supports our new findings, which revealed decreasing bile acid levels 1 year after SG in the patients with obesity and T2DM, and the negative relationship between FGF 19 and total bile acid. The gene discussed is FGF19; the disease is type 2 diabetes mellitus.